2003
DOI: 10.1016/s0145-2126(02)00058-9
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxic and inhibitory effects of 4,4′-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(31 citation statements)
references
References 18 publications
0
31
0
Order By: Relevance
“…All the analogues were compared with the basic unsubstitutedchalcone to dertermine the cytotoxic activity.The present results demonstrate that the chalcones and their analogues inhibit the proliferation of Jurkat (human T-lymphocyte leukemia) cells by triggering apoptosis.Among them the analogues 4 and 15 exhibited most potent cytotoxicity than the parental basic chalconemolecule [26]. All the test compounds have also shown cytotoxic activity (in a concentration dependent manner) against HL-60 cells [27].The most active analogues 4 and 15 on Jurkat cells exhibited activity similar to the parental molecule against HL-60.In this case, the analogues 7 and 12 have shown the more significant activity against HL-60 cells than the parental compound, but they were not more active than the parent molecule in the case of Jurkat cells. Among the synthesized chalcones,the most active compounds were 4,15 and their IC50 values on T cell leukemia (Jurkat) cells were 1.6x10-2 mM,1.7x10-2 mM respectively.…”
Section: Biological Screening Methodology:assay Methods Of Cytotoxic Amentioning
confidence: 96%
“…All the analogues were compared with the basic unsubstitutedchalcone to dertermine the cytotoxic activity.The present results demonstrate that the chalcones and their analogues inhibit the proliferation of Jurkat (human T-lymphocyte leukemia) cells by triggering apoptosis.Among them the analogues 4 and 15 exhibited most potent cytotoxicity than the parental basic chalconemolecule [26]. All the test compounds have also shown cytotoxic activity (in a concentration dependent manner) against HL-60 cells [27].The most active analogues 4 and 15 on Jurkat cells exhibited activity similar to the parental molecule against HL-60.In this case, the analogues 7 and 12 have shown the more significant activity against HL-60 cells than the parental compound, but they were not more active than the parent molecule in the case of Jurkat cells. Among the synthesized chalcones,the most active compounds were 4,15 and their IC50 values on T cell leukemia (Jurkat) cells were 1.6x10-2 mM,1.7x10-2 mM respectively.…”
Section: Biological Screening Methodology:assay Methods Of Cytotoxic Amentioning
confidence: 96%
“…In addition, a huge array of hemisynthetic or synthetic chalcone analogues has been created to identify the most efficient structure for the inhibition of proliferation (see Table 1) [9,91,95,145,148,156,179].…”
Section: Effect Of Chalcones On Tumor Progressionmentioning
confidence: 99%
“…Several chalcones have been isolated or synthesized, and their cytotoxicity on cancer cell lines and their anticancer activity in cancer animal models have been reported. 11,12 Furthermore, the molecular mechanisms of the anticancer action of chalcones have also been investigated. The chalcones exhibited anticancer activity through multiple mechanisms including cell cycle disruption, angiogenesis inhibition, tubulin polymerization inhibition, apoptosis induction and blockade of the nuclear factorkappa B (NF-κB) signaling pathway.…”
Section: Introductionmentioning
confidence: 99%